Emma Court

Redefining Philanthropic Drug Discovery

Emma Court, Bob Crutchfield, Kathy Giusti, John Rigg, Todd Sherer

Representative non-profits including the Multiple Myeloma Research Foundation, American Cancer Society, and Michael J. Fox Foundation are deploying specialized venture funds and pre-competitive consortia to accelerate drug development through strategic data ownership and direct investment. These entities face significant structural challenges regarding talent acquisition, donor reluctance to forgo financial returns, and the lack of viable reimbursement models for critical areas like antimicrobial stewardship. Panelists recommend that organizations conduct rigorous landscape assessments and adopt neutral, execution-focused investment strategies to bridge the gap between philanthropy and commercial innovation without crowding out private sector growth.